← All Nextcure, INC filings

Nextcure, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
NXTC
Nextcure, INC
SCHEDULE: Sofinnova Updates NextCure Stake to 7.1% After Dilution
Sofinnova Venture Partners IX and affiliates updated their beneficial ownership in NextCure, Inc. to 7.1% of common stock, reflecting dilution from recent stock sales.